DUBLIN–(BUSINESS WIRE)–The “Global gRNA Market Size, Share & Trends Analysis Report by Product & Services (Products, Custom gRNA Synthesis Services), gRNA Type (Research-Use), Application, End-use, Region, and Segment Forecasts, 2024-2030” report has been added to ResearchAndMarkets.com’s offering.
The global gRNA (guide RNA) market is witnessing an unprecedented surge, with projections estimating its growth to reach USD 1.62 billion by 2030, expanding at a compound annual growth rate (CAGR) of 18.6% from 2024 to 2030. A comprehensive market analysis reveals the critical drivers of this robust growth, led by the accelerating adoption of Next-Generation Sequencing (NGS) technologies and significant investments in research and development within the biomedical sector.
Key Insights:
The latest market report on the global gRNA industry, now available for review, emphasizes the utility of products and custom gRNA synthesis services, and the ever-expanding realm of research applications. The impact of NGS on the gRNA market underscores the evolving landscape of genomic research and medicine, fostering a conducive environment for innovative therapeutic solutions and genetic advancements.
- Product and services within the gRNA market, especially those that enhance gene editing accuracy and efficiency, constituted a commanding market share of 73.4% in 2023, signaling a continued upward trajectory.
- The research-use gRNA type segment remains at the forefront, buoyed by a multitude of research initiatives necessitating high-caliber gRNA, thereby catalyzing its demand.
- Genome engineering applications have taken the lead, reflecting the sector’s burgeoning need for cutting-edge genetic tools in both academic exploration and therapeutic intervention.
- Pharmaceutical and biotechnology companies are leveraging gRNA to pioneer advancements in precision medicine, positioning themselves as key end-users and market growth propellants.
- Regionally, North America has emerged as a dominant player, accounting for over half of the global revenue share in 2023, a testament to the concentration of market innovators and a robust research infrastructure in the region.
Strategic Advancements:
In October 2023, the industry saw a quantum leap with the introduction of IND-enabling (INDe) gRNAs, designed to meet the stringent guidelines for Good Laboratory Practice (GLP) in preclinical and IND-enabling studies. This advancement exemplifies the continuous strive toward refining CRISPR-based cell and gene therapies, an endeavor that is expected to propel market dynamics alongside concomitant innovation.
Regional Market Performance and Prospects
The gRNA market report highlights the regional nuances and contributions, with North America at the helm. The synergy between innovative biotechnological endeavors and a favorable regulatory framework has solidified the region’s leadership position in the global arena.
Market Expansion and Future Outlook:
The overall demand for gRNA across various application segments and end-use industries delineates a positive growth pattern, with future market expansion and scalability being driven by both established industry veterans and emergent start-ups. The integration of advanced technologies and the discovery of novel applications are key to sustaining this growth momentum.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 110 |
| Forecast Period | 2023 – 2030 |
| Estimated Market Value (USD) in 2023 | $497.9 Million |
| Forecasted Market Value (USD) by 2030 | $1620 Million |
| Compound Annual Growth Rate | 18.6% |
| Regions Covered | Global |
Companies Mentioned
- Thermo Fisher Scientififc, Inc
- Agilent Technologies, Inc.
- System Biosciences, LLC.
- Jena Bioscience GmbH
- Merck KGaA
- Azenta Life Sciences (Genewiz)
- Takara Bio Inc.
- Synbio Technologies
- Revvity Inc (Horizon Discovery Ltd.)
- Synthego
For more information about this report visit https://www.researchandmarkets.com/r/ont90n
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900